Selected article for: "available specific treatment and coronavirus infection"
Author: Sahebnasagh, Adeleh; Avan, Razieh; Saghafi, Fatemeh; Mojtahedzadeh, Mojataba; Sadremomtaz, Afsaneh; Arasteh, Omid; Tanzifi, Asal; Faramarzi, Fatemeh; Negarandeh, Reza; Safdari, Mohammadreza; Khataminia, Masoud; Rezai Ghaleno, Hassan; Habtemariam, Solomon; Khoshi, Amirhosein
Title: Pharmacological treatments of COVID-19
  • Cord-id: rqlzhzqr
  • Document date: 2020_8_20
    • ID: rqlzhzqr
    Snippet: The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since the
    Document: The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since there is no specific treatment available for SARS-CoV2 infection, and or COVID-19, several clinical and sub-clinical studies are currently undertaken to find a gold-standard therapeutic regimen with high efficacy and low side effect. Based on the published scientific evidence published to date, we summarized herein the effects of different potential therapies and up-to-date clinical trials. The review is intended to help readers aware of potentially effective COVID-19 treatment and provide useful references for future studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s43440-020-00152-9) contains supplementary material, which is available to authorized users.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and action mechanism: 1
    • accessory protein and active site: 1, 2
    • accessory protein and acute ards respiratory distress syndrome: 1
    • ace activation and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • acid aspiration and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid chain and action mechanism: 1, 2
    • acid chain and active form: 1, 2
    • acid chain and active site: 1
    • acid chain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • active form and acute ards respiratory distress syndrome: 1